Every story in this section, newest first — page 171 of 373.
CollPlant Biotechnologies (NASDAQ:CLGN) initiated a formal review of its strategic alternatives after a sharp contraction in milestone revenue caused its first-quarter sales to drop to near-zero, forcing the company to slash its workforce by half.
The Buckle (NYSE:BKE) reported a significant increase in first-quarter profitability, driven by steady brick-and-mortar sales growth and an injection of cash from a finalized legal settlement.
International Flavors & Fragrances (NYSE:IFF) agreed to sell its Food Ingredients division to funds advised by CVC Capital Partners in a transaction valuing the unit at approximately $4.3 billion.
Genesco (NYSE:GCO) reported first-quarter revenue that surpassed Wall Street expectations, driven by a modest recovery in brick-and-mortar retail traffic that countered stagnant growth across its e-commerce segments.
Merck (NYSE:MRK) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to its investigational oral drug calderasib when paired with the company’s blockbuster immunotherapy Keytruda, accelerating its development path for newly diagnosed lung cancer patients.
Noah Holdings (NYSE:NOAH) reported a sharp acceleration in operating profitability for the first quarter of 2026, as a structural rebound in domestic wealth management clients and stringent cost controls offset flat revenues and equity asset volatility.
Chagee Holdings (NASDAQ:CHA) reported a rise in first-quarter revenue as aggressive international expansion partially offset cooling demand in its home market, though a sharp contraction in operating margins drove net income down by more than a third.
Natera (NASDAQ:TRA) has entered into a clinical collaboration with Diakonos Oncology to deploy its liquid biopsy technology to track patient responses during an active trial for an aggressive skin cancer therapy.
BeOne Medicines (NASDAQ:ONC) is moving to advance the treatment paradigm for chronic lymphocytic leukemia (CLL) with extensive long-term follow-up data slated for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
Shares of Dell Technologies (NYSE:DELL) soared nearly 40% in premarket trading on Friday after robust demand for its Nvidia-powered artificial intelligence servers prompted the hardware giant to sharply raise its annual revenue and profit forecasts.
BitFuFu (NASDAQ:FUFU) reported a decline in first-quarter revenue as a volatile downturn in Bitcoin valuations triggered a heavy asset write-down, eclipsing operational growth across the company's core cloud infrastructure services.
Oil prices stabilized on Friday but remained on track for their sharpest weekly decline since early April, as investors weighed reports of a tentative ceasefire extension between the U.S. and Iran against a backdrop of lingering political hurdles.
The U.S. Food and Drug Administration approved AstraZeneca's (NYSE:AZN) blockbusting immunotherapy Imfinzi (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy, marking a major regulatory expansion for the company’s oncology franchise into earlier-stage disease.
Johnson Outdoors (NASDAQ:JOUT) announced that its Board of Directors has formally approved its latest quarterly cash dividend, maintaining the company’s long-standing commitment to steady capital returns for both classes of its publicly traded stock.
The U.S. Surface Transportation Board accepted a revised merger application from Union Pacific (NYSE:UNP) and Norfolk Southern (NYSE:NSC) on Thursday but immediately froze all formal proceedings, dealing a tactical setback to the proposed $85 billion megadeal.
Newegg Commerce (NASDAQ:NEGG) reported a profitable turnaround for the first quarter of 2026, showcasing improved operational leverage and cost-containment measures that allowed the company to reverse a prior-year loss despite an ongoing contraction in top-line retail sales.
Seanergy Maritime (NASDAQ:SHIP) reported a sharp acceleration in first-quarter earnings, driven by a significant expansion in its top-line revenue and optimal market conditions for its heavy-capacity dry bulk vessels.
Toro Corp. (NASDAQ:TORO) reported a decline in first-quarter net income as escalating operational costs outpaced top-line growth, though the shipping company leveraged its robust liquidity reserves to clear a new credit line and push through massive cash payouts to equity holders.
Eli Lilly (NYSE:LLY) announced a major commercial milestone for its metabolic health franchise, securing comprehensive formulary placement from the three largest pharmacy benefit managers (PBMs) in the United States to cover its entire obesity medicine portfolio.
Athens-based dry bulk vessel operator Diana Shipping (NYSE:DSX) reported a multi-fold increase in first-quarter net income, showcasing high operational efficiency across its global maritime fleet despite a minor contraction in aggregate time charter revenues.
Vyome Holdings (NASDAQ:HIND) reported an expanded cash runway for the first quarter of 2026, leveraging a recent equity injection to fund regulatory steps and clinical trial preparations for its immuno-inflammatory and rare disease pipeline.
CECO Environmental (NASDAQ:CECO) and Thermon Group Holdings (NYSE:THR) secured near-unanimous approval from their respective stockholders for their pending strategic combination, clearing the final major execution hurdle toward building a consolidated industrial environmental and process thermal solutions provider.
Formula Systems (NASDAQ:FORTY) reported record financial results for the first quarter of 2026, driven by double-digit revenue expansion across its global technology portfolio and the finalization of a massive software consolidation merger.
Photronics (NASDAQ:PLAB) reported a sequential contraction in second-quarter revenue, navigating near-term headwinds in chip-sector product launches even as demand for high-end mobile and automotive display components provided a resilient partial buffer.
